• Aucun résultat trouvé

Electrochemical determination of naloxone using molecularly imprinted poly(para-phenylenediamine) sensor

N/A
N/A
Protected

Academic year: 2021

Partager "Electrochemical determination of naloxone using molecularly imprinted poly(para-phenylenediamine) sensor"

Copied!
7
0
0

Texte intégral

(1)

0.0

0.3

0.6

0.9

1.2

1.5

-50

0

50

100

150

Cur

re

nt

(

mA

)

Potential (V) vs. Ag/AgCl

rGO-AuNP/SPCE rGO/SPCE Bare SPCE (A)

Supplementary Figure S1. (A) The appearance of gold oxidation peak at +0.63 V in the rGO-AuNP/SPCE, but the lack of this peak on the other two electrode surfaces, indicates the presence of gold on this electrode material. The presence of anodic currents at potentials >+1.0 V in the CV profiles of the rGO/SPCE and rGO-AuNPs/SPCE surfaces vs the bare SPCE at potentials indicates the oxidation of rGO on the modified electrodes. (B) CVs of 5 mM [Fe(CN)6]3-/4-in the three electrode materials show that current (by implication electroactive surface area of the electrode) is higher for the rGO-AuNPs modified electrode than the rGO modified and bare electrodes.

-0.2 0.0 0.2 0.4 0.6

-150

-75

0

75

150

Current

(

mA

)

Potential (V) vs. Ag/AgCl

Bare SPCE rGO/SPCE rGO-AuNP/SPCE (B)

(2)

Supplementary Figure S2. CVs of 5 mM [Fe(CN)6]3-/4- at a scan rate of 50 mV/s using (a) rGO-AuNPs/SPCE, (b) NIP/rGO-AuNPs/SPCE after soaking in the extraction solution and (c) MIP/rGO-AuNPs/SPCE after removal of NLX using extraction solution.

-0.2

0.0

0.2

0.4

0.6

-150

-75

0

75

150

c

Current

(µA)

Potential (V) vs. Ag

b

a

(3)

0 10 20 30 40 10 15 20 25 30 Current (µA )

Extraction time (min)

(A) 0 5 10 15 20 0 10 20 30 Current (µA )

Incubation time (min)

(B)

Supplementary Figure S3. Variation in peak current as a function of (a) extraction time and (b) incubation time of 50 mM NLX in the MIP/rGO-AuNPs/SPCE sensor.

(4)

Supplementary Figure S4. Scatchard plot of the binding of NLX to the MIP/rGO-AuNPs/SPCE sensor. Plot was generated from the data shown in Figure 6 using the Scatchard equation DI/Io/[NLX] =

{(DI/Io)max – DI/Io}/Kd.

0.0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.04

0.06

0.08

0.10

D

I/I

o

/[NLX]

(m

M

-1

)

DI/I

o Equation y = a + b*x Plot B Weight No Weighting Intercept 0.10707 ± 0.00492 Slope -0.10255 ± 0.01107

Residual Sum of Squares 2.93767E-4

Pearson's r -0.9668

R-Square (COD) 0.93471

(5)

Supplementary Figure S5. Chemical structures of the analyte naloxone, and the structurally similar molecules (morphine, naltrexone and noroxymorphone) tested in study.

(6)

Surface DIaverage (mA) Io(mA) STDV

MIP/rGO-AuNPs/SPCE 16.75 50.90 0.03 NIP/rGO-AuNPs/SPCE 0.86 13.72 0.02 MIP/rGO/SPCE 7.75 38.77 0.01

MIP/SPCE 4.22 40.02 0.04

(7)

Supplementary Table S2. List of ingredients in artificial urine

Ingredient Concentration (g/L)

Urea 25

Sodium chloride 9

Disodium hydrogen orthophosphate, anhydrous 2.5 Potassium dihydrogen orthophosphate 2.5

Ammonium chloride 3

Creatinine 2

Références

Documents relatifs

pare the propagation of slow waves and bursts of spike potential, the propagation during dif- ferent phases of activity, during feeding or fas-. ting or

The second aspect of the AB effect exhibits that the force concept gradually fades away in Quantum Mechanics2. Instead of forces,

L’accès aux archives de la revue « Annali della Scuola Normale Superiore di Pisa, Classe di Scienze » ( http://www.sns.it/it/edizioni/riviste/annaliscienze/ ) implique l’accord

Riesz interpolation theorem interpolation between these endpoint results clearly yields (2.3) and (2.4).. Assume

Dans la caractérisation des manifestations extra-digestives persistantes sous traitement prolongé ( 3 mois) par IPP double dose la pHimpédancemétrie est réalisée en maintenant

 Reflux duodéno-gastrique de matériel non acide (bile, secrétions pancréatiques) et présence de bile et de trypsine dans l’œsophage directement détectable par aspiration..

Une méta-analyse [17] ayant inclus 34 essais avec près de 10000 patients- années a retrouvé une incidence de 3,8 adénocarcinomes œsophagiens pour 1 000 patients-années dans

• Pour les patients symptomatiques sous IPP, après optimisation du traitement, une évaluation step by step avec ph-. impédancemétrie permet de sélectionner les candidats à la